In a recent study on non-small cell lung cancer (NSCLC), TIL-Bs directly isolated from cancer samples were shown to stimulate autologous CD4+ TIL-Ts in vitro, providing empirical evidence to support this mechanism [25]. Here, CD4 is linked to non-small cell lung carcinoma.